In addition, mutations in topoisomerase DNA II-binding protein 1 (TOPBP1) are also associated with PAH susceptibility, maintenance of genomic integrity, prevention of DNA damage during replication, and promotion of PAEC amplification and apoptosis resistance [25]. The gene discussed is TOPBP1; the disease is pulmonary arterial hypertension.